Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...